Table 3 Pharmacist willingness to engage in harm reduction services for specified populations
|  | Urban (n = 232) | Rural (n = 68) | Urban/rural p-value |
|---|---|---|---|
% (n) | % (n) | ||
Willingness to sell non-prescription syringes to:a | |||
 Patients with diabetes | |||
  Willing | 81.5 (189) | 82.4 (56) | 0.66 |
  Not willing | 2.2 (5) | 2.9 (2) |  |
 Suspected persons who inject drugs | |||
  Willing | 51.7 (120) | 41.2 (28) | 0.07 |
  Not willing | 31.9 (74) | 44.1 (30) |  |
 Persons who inject drugs who have a referral to purchase syringes | |||
  Willing | 61.6 (143) | 51.2 (35) | 0.049 |
  Not willing | 22.0 (51) | 33.8 (23) |  |
Willingness to dispense naloxone to:b | |||
 Patient with naloxone co-prescription from physician | |||
  Willing | 99.6 (224) | 94.1 (64) | 1.00 |
  Not willing | 1.3 (3) | 1.5 (1) |  |
 Suspected persons who inject drugs | |||
  Willing | 84.1 (195) | 79.4 (54) | 0.57 |
  Not willing | 13.8 (32) | 16.2 (11) |  |
 Third parties of individuals who may be at increased risk of opioid overdose | |||
  Willing | 90.1 (209) | 85.3 (58) | 0.47 |
  Not willing | 7.8 (18) | 10.3 (7) |  |
 Patient with an opioid prescription | |||
  Willing | 93.5 (217) | 89.7 (61) | 0.52 |
  Not willing | 4.3 (10) | 5.9 (4) |  |